221 related articles for article (PubMed ID: 20951505)
21. TARGIT-E(lderly)--prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.
Neumaier C; Elena S; Grit W; Yasser AM; Uta KT; Anke K; Axel G; Marc S; Frederik W
BMC Cancer; 2012 May; 12():171. PubMed ID: 22569123
[TBL] [Abstract][Full Text] [Related]
22. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients.
Reitsamer R; Peintinger F; Sedlmayer F; Kopp M; Menzel C; Cimpoca W; Glueck S; Rahim H; Kopp P; Deutschmann H; Merz F; Brandis M; Kogelnik H
Eur J Cancer; 2002 Aug; 38(12):1607-10. PubMed ID: 12142049
[TBL] [Abstract][Full Text] [Related]
24. A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients.
Ahn SG; Bae SJ; Lee HW; Yoon CI; Kim JW; Lee IJ; Jeong J
Breast Cancer Res Treat; 2019 Feb; 174(1):157-163. PubMed ID: 30467660
[TBL] [Abstract][Full Text] [Related]
25. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
26. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases.
Veronesi U; Orecchia R; Luini A; Galimberti V; Gatti G; Intra M; Veronesi P; Leonardi MC; Ciocca M; Lazzari R; Caldarella P; Simsek S; Silva LS; Sances D
Ann Surg; 2005 Jul; 242(1):101-6. PubMed ID: 15973107
[TBL] [Abstract][Full Text] [Related]
27. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer.
Chang DW; te Marvelde L; Chua BH
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):73-9. PubMed ID: 24331652
[TBL] [Abstract][Full Text] [Related]
29. Breast conserving surgery with targeted intraoperative radiotherapy for the management of ductal carcinoma in situ.
Banks A; Coronado G; Zimmerman R; Iyengar G; Holmes DR
J Surg Oncol; 2019 Mar; 119(4):409-420. PubMed ID: 30589080
[TBL] [Abstract][Full Text] [Related]
30. Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays.
Herskind C; Griebel J; Kraus-Tiefenbacher U; Wenz F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1575-81. PubMed ID: 19028280
[TBL] [Abstract][Full Text] [Related]
31. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer.
Vaidya JS; Baum M; Tobias JS; D'Souza DP; Naidu SV; Morgan S; Metaxas M; Harte KJ; Sliski AP; Thomson E
Ann Oncol; 2001 Aug; 12(8):1075-80. PubMed ID: 11583188
[TBL] [Abstract][Full Text] [Related]
32. A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer.
Sperk E; Astor D; Keller A; Welzel G; Gerhardt A; Tuschy B; Sütterlin M; Wenz F
Radiat Oncol; 2014 Jul; 9():154. PubMed ID: 25015740
[TBL] [Abstract][Full Text] [Related]
33. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
[TBL] [Abstract][Full Text] [Related]
34. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
35. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
36. Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation.
Oses G; Cases C; Valduvieco I; Farrús B; Alonso I; Caparrós X; Mases J; Muñoz-Guglielmetti D; Biete A; Castro C; Escudero E; Molina M; Herreros A; Saez J; Mollà M
Clin Transl Oncol; 2021 Aug; 23(8):1593-1600. PubMed ID: 33534078
[TBL] [Abstract][Full Text] [Related]
37. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
38. A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.
Kindts I; Verhoeven K; Laenen A; Christiaens M; Janssen H; Van der Vorst A; Van Limbergen E; Weltens C
Strahlenther Onkol; 2019 Apr; 195(4):310-317. PubMed ID: 30603857
[TBL] [Abstract][Full Text] [Related]
39. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
[TBL] [Abstract][Full Text] [Related]
40. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A.
Sperk E; Welzel G; Keller A; Kraus-Tiefenbacher U; Gerhardt A; Sütterlin M; Wenz F
Breast Cancer Res Treat; 2012 Aug; 135(1):253-60. PubMed ID: 22842984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
